The new requirements and application of Measures for Ethical Review of Life Sciences and Medical Research Involving Human Beings on conflict of interests governance
10.3760/cma.j.cn113565-20230731-00026
- VernacularTitle:《涉及人的生命科学和医学研究伦理审查办法》对利益冲突治理的适用研究
- Author:
Jian TANG
1
;
Haihong ZHANG
Author Information
1. 天津医科大学医学人文学院 300070
- Keywords:
Medical research ethics;
Conflict of interests;
Institutional review boards;
Ethical governance
- From:
Chinese Journal of Medical Science Research Management
2023;36(6):413-418
- CountryChina
- Language:Chinese
-
Abstract:
Objective:This study aims to critically assess the 2023 updates in the governance of Conflicts of Interests (COIs) as outlined in the Ethical Review Measures for Life Sciences and Medical Research Involving Human Beings. It seeks to delve into the ethical implications of these new mandates and offers concrete strategies for effectively integrating them into ethics review practices.Methods:We conducted a comparative analysis of the COIs-related provisions in the 2016 Ethical Review Measures for Biomedical Research Involving Humans, examining them alongside current trends and challenges in COIs governance and ethics review practices.Results:The study identified key challenges posed by COIs to medical research ethics and addresses three principal areas for normative application: the declaration process for conflicts of interest, enhancing the COIs management framework, and the critical review points for COIs by ethics committees.Conclusions:In light of the international consensus on COIs governance, we advocate for the advancement of conflict of interest management at the institutional level. This includes a focus on informed consent processes, the development of robust systems within medical institutions, and the facilitation of ethical corporate collaborations.
